Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Fort Collins, CO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Innosphere Ventures Fund is thrilled to announce a significant follow-on investment in GelSana, a groundbreaking company in the advanced wound...
-
LOS ANGELES, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”) a clinical-stage biopharmaceutical company pioneering personalized therapies...
-
ROCKVILLE, Md., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Today the American Kidney Fund (AKF) released a new report that urges policymakers and advocates to broadly support measures—including improved...
-
Enhanced 250kg manufacturing facility assures increased capacity to meet rapidly growing ZTlido® demand.Two new patents previously announced covering ZTlido® in the U.S. ensures proprietary protection...
-
New results from six patients with HGTa papillary tumors show five of six patients with HGRFS at Week 12Data continue to support favorable tolerability of TARA-002 in patients with NMIBCAs previously...
-
ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office,...
-
HANOVER, MD, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
-
FORT WORTH, Texas, Nov. 30, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
-
LOS ANGELES, Nov. 30, 2023 (GLOBE NEWSWIRE) -- TruVivoTM, a pioneering all-human 2D+ hepatic system that supports ADME/DMPK, toxicology and disease modeling applications, has been selected as the...
-
FARMINGTON HILLS, Mich., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing...
-
SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
-
FORT WORTH, Texas, Nov. 30, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
-
The PROGRESS study marks initiation of the late-stage development program for AAK1 inhibitor LX9211, with potential to become the first new, non-opioid drug therapy in high-unmet need neuropathic pain...
-
Chicago, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Particle Size Analysis Market in terms of revenue was estimated to be worth $446 million in 2023 and is poised to reach $596 million by 2028, growing at a...
-
Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
-
CHESTERBROOK, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
-
HAYWARD, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
-
Company to review BXCL502 and other potential emerging pipeline candidates Dr. Jeffrey Cummings to discuss agitation relief in Alzheimer’s disease and BXCL502 as a potential treatment Dr. Sandra...
-
SGT-610 has “Orphan Drug” designation status in the U.S. and E.U. and “Breakthrough Therapy” designation status in the U.S., as potentially the first and only therapy aimed at preventing new BCCs in...
-
NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
-
Jersey City, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Cryopreservation Bags and Freezing Bags Market Size,...
-
WINSTON-SALEM, N.C., Nov. 30, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease...
-
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global CNS Therapeutics Market to...
-
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "Carnauba Wax Market Size, Share & Trends Analysis Report By Product (Type 1, Type 3, Type 4), By Application (Cosmetics, Food, Automotive,...
-
Vancouver, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The global mammography system market is expected to reach USD 2.19 Billion by 2022, according to a new report by Emergen Research. The market for...
-
Företagsmeddelande, Helsingfors, 30.11.2023 kl. 10.00 (EET) Nexstim Abp byter Certified Advisor till Carnegie Investment Bank AB (publ) Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar...
-
Company announcement, Helsinki, 30 November 2023 at 10 AM (EET) Nexstim Plc Changes Certified Advisor to Carnegie Investment Bank AB (publ) Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") today...
-
Burning Rock Reports Third Quarter 2023 Financial Results
-
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States DONESTA® for the treatment of vasomotor symptoms of menopause, is expected to target...
-
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
-
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
-
PROVIDENCE, Rhode Island, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 22, 2023, it received a notice from The Nasdaq Stock Market...
-
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been...
-
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations at the 34th International Symposium on ALS/MND taking...
-
MELBOURNE, Australia and NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ: IXHL) is pleased to announce that its previously announced transaction to redomicile Incannex...
-
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Outlook Therapeutics, Inc. ("Outlook" or the "Company") (NASDAQ: OTLK) of a class action securities...
-
New York, USA, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Tendinopathy Market to Register Incremental Growth During the Study Period (2019–2032), Estimates DelveInsight | Leading Companies in the Market - ...
-
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Evoke Neuroscience, a pioneer in the field of cognitive health, is proud to announce the donation of an Evoke EEG System to Ukrainian friends in Lviv....
-
LOS ANGELES, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 2, 2024 deadline to file a lead plaintiff motion in the class action...
-
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TytoCare, a virtual care company enabling health plans and providers to deliver accessible, high-quality remote primary care anywhere across the country,...
-
Hairmax's Dedication to Growth is Reflected in Extraordinary Black Friday–Cyber Monday Sales BOCA RATON, Fla., Nov. 29, 2023 (GLOBE NEWSWIRE) -- In a standout Black Friday week, Hairmax®, the...
-
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of...
-
BI 764532 is an investigational T-cell engager that redirects T cells towards cancer cells expressing the DLL3 protein DLL3 antigen was discovered using OBT’s proprietary OGAP® drug discovery...
-
TRYBE Labs to provide MangoRx customers with turnkey at-home blood collection services and solutions Dallas, Texas, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx”...
-
MINNEAPOLIS, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet...
-
HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next...
-
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
-
FDA has set a PDUFA target action date of July 07, 2024Atopic dermatitis affects approximately 16.5 million adults and 9.6 million children in the United StatessNDA supported by positive efficacy and...
-
New York, United States, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The Global Rotator Cuff Injury Treatment Market Size is to Grow from USD 1.04 Billion in 2022 to USD 1.66 Billion by 2032, at a Compound...
-
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker Endpoints Sponsor Identified Issues Relating to...